Knowledge and Attitude of Pregnant Women Towards Preeclampsia in Assiut Governorate

July 17, 2025 updated by: Gehad Khalaf Refaey, Assiut University

Knowledge and Attitude of Pregnant Women Towards Preeclampsia and Its Associated Factors in Assuit University Women's Health Hospital.

Our study will be a cross sectional study to evaluate the knowledge level and attitude of pregnant women towards preeclampsia and factors affecting it ,the study will be done at Assiut University Hospitals - Women's Health Hospital. all pregnant women who will come to ANC visits will be included .the study tool is a well structured questionnaire for assessment of our outcomes.

Study Overview

Status

Completed

Conditions

Detailed Description

Preeclampsia is a pregnancy-related hypertensive disorder that usually occurs after 20 weeks of gestation. It is characterised by hypertension and proteinuria . Preeclampsia is the leading cause of maternal death, complicating about one-tenth of all pregnancies worldwide . It is the second greatest cause of direct maternal death, accounting for 70,000 maternal mortality globally each year .The burden of preeclampsia and eclampsia is most significant in low- and middle-income countries (LMICs), where hypertensive disorders of pregnancy account for 10-15% of maternal deaths.

Early detection of symptoms, rapid presentation to healthcare facilities, and subsequent management with antihypertensive medications, magnesium sulphate, and delivery of the foetus and placenta improve outcomes in pregnancies complicated by preeclampsia and eclampsia . As a result, ANC visits and intrapartum admission are critical chances for patient counselling Despite the essential relationship between women's awareness of preeclampsia and health seeking behaviour, research on this topic is limited, particularly in underdeveloped countries. Even in developed countries, studies in high-income countries show that only half of patients were counselled about preeclampsia signs and symptoms, despite the fact that counselling by healthcare personnel is related to higher patient knowledge. So there is a gap in studying pregnant women's knowledge and attitudes concerning preeclampsia in underdeveloped countries, particularly Egypt, where studies on this topic are scarce.

Study Type

Observational

Enrollment (Actual)

261

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Asyut, Egypt, 71515
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All pregnant women in first, second and third trimester who will come to receive antenatal care (ANC) services

Description

Inclusion Criteria:

  • All pregnant women.
  • pregnant women in first, second and third trimester.
  • pregnant women who come to receive ANC at Assiut University Hospitals - Women's Health Hospital out patient clinic.

Exclusion Criteria:

  • Pregnant women that are unwell to give consent.
  • Pregnant women who are already diagnosed by preeclampsia and eclampsia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Knowledge of pregnant women about preeclampsia
Time Frame: just after ending the interview in which we filled in questionnaire
assessement of knowledge"poor,moderate or good " by answering a structured questionnaire .The women will answer by yes , no or I don't know , A scoring system, where a correct answer attracts a score of one (1) and a wrong or no response (or I don't know) attracts a score of zero (0) was used to scale participants' knowledge of preeclampsia . The scores were expressed as percentages and Bloom's cut-off point will be employed to classify knowledge of PE into three levels: poor (< 60%), moderate (60-80%) and good (80-100%).high score means a better outcome .
just after ending the interview in which we filled in questionnaire
Attitude of pregnant women towards preeclampsia
Time Frame: just t after ending the interview in which we filled in questionnaire
assessement of attitude ""positive ,neutral or negative " by answering a structured questionnaire.The women will answer by agree ,disagree or unsure , Attitude was reported as positive, neutral and negative when they scored 80-100 %, 60-79 %, and less than 60 % of the attitude assessment questions respectively using the Bloom's cut-off point.
just t after ending the interview in which we filled in questionnaire
Associated factor with knowledge and attitude of pregnant women towards preeclampsia
Time Frame: through study completion, an average of 1 year
studying sociodemographic ,medical and obstetric factors that affect knowledge and attitude of pregnant women towards preeclampsia by well structured questionnaire "by the previous scale"
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ahmed M Abbas, MD, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

December 1, 2024

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

July 12, 2023

First Submitted That Met QC Criteria

July 19, 2023

First Posted (Actual)

July 21, 2023

Study Record Updates

Last Update Posted (Actual)

July 20, 2025

Last Update Submitted That Met QC Criteria

July 17, 2025

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preeclampsia

Subscribe